Lewis Tanya
SEC CIK 1451038 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| REPL | Replimune Group, Inc. | Chief Dev.Op Off | 135.3K | — | $609.6K | 5 | 2022-04-01 | 2023-06-13 |
Most active insiders at REPL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Patel Sushil | CEO, Dir | — | $811.2K |
| 2 | Hill Emily Luisa | CFO | — | $320.3K |
| 3 | Xynos Konstantinos | Chief Medical Off | — | $285.7K |
| 4 | Sarchi Christopher | Chief Commercial Off | — | $254.2K |
| 5 | Schwendenman Andrew | CAO | — | $139.1K |
| 6 | Astley-Sparke Philip | Dir | — | $89.7K |
| 7 | Dhingra Kapil | Dir | — | $33.0K |
Lewis Tanya made no open-market trades at REPL in the last 12 months.
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-06-15 | 2023-06-13 | REPL | Replimune Group, Inc. | Lewis Tanya | Chief Dev. Op. Off | S - Sale | $24.06 | -12.9K | 135.3K | -9% | -$309.4K |
| 2023-05-18 | 2023-05-16 | REPL | Replimune Group, Inc. | Lewis Tanya | Chief Dev. Op. Off | S - Sale | $18.05 | -12.2K | 148.2K | -8% | -$220.3K | |
| D | 2023-04-04 | 2023-04-01 | REPL | Replimune Group, Inc. | Lewis Tanya | Chief Dev. Op. Off | A - Grant | $0.00 | +40.0K | 160.4K | +33% | $0 |
| 2022-05-18 | 2022-05-16 | REPL | Replimune Group, Inc. | Lewis Tanya | Chief Dev. Op Off | S - Sale | $14.59 | -5,473 | 120.4K | -4% | -$79.9K | |
| D | 2022-04-05 | 2022-04-01 | REPL | Replimune Group, Inc. | Lewis Tanya | Chief Dev.Op Off | A - Grant | $0.00 | +52.5K | 125.8K | +72% | $0 |
Purchase Sale Sale after option exercise All abbreviations